Wenjing H. Zhang

Key Laboratory Of Medicine And Health Of Shandong Province
Weifang, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

A mutational process signature and genomic alterations associated with outcome and immunogenicity in cancers with brain metastasis.

A mutational process signature and genomic alterations associated with outcome and immunogenicity in cancers with brain metastasis.

Journal: Frontiers in immunology

Published: April 08, 2025

FAT1 mutation-related signature predicts survival risk and tumor immunogenicity in lung adenocarcinoma.

FAT1 mutation-related signature predicts survival risk and tumor immunogenicity in lung adenocarcinoma.

Journal: Frontiers in genetics

Published: July 18, 2024

Screening of key immune-related gene in Parkinson's disease based on WGCNA and machine learning.

Screening of key immune-related gene in Parkinson's disease based on WGCNA and machine learning.

Journal: Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences

Published: May 16, 2024

Somatic mutational landscape reveals mutational signatures and significantly mutated genes of cancer immunotherapeutic outcome and sex disparities.

Somatic mutational landscape reveals mutational signatures and significantly mutated genes of cancer immunotherapeutic outcome and sex disparities.

Journal: Frontiers in immunology

Published: April 26, 2024

Lipoproteins and metabolites in diagnosing and predicting Alzheimer's disease using machine learning.

Lipoproteins and metabolites in diagnosing and predicting Alzheimer's disease using machine learning.

Journal: Lipids in health and disease

Published: February 15, 2024

Identification of Alzheimer's disease biomarkers and their immune function characterization.

Identification of Alzheimer's disease biomarkers and their immune function characterization.

Journal: Archives of medical science : AMS

Published: October 19, 2023

Exploring biomarkers of MAPK pathway co-expression in lung adenocarcinoma and their functions based on machine learning algorithms and single-cell analysis.

Exploring biomarkers of MAPK pathway co-expression in lung adenocarcinoma and their functions based on machine learning algorithms and single-cell analysis.

Journal: Genes & diseases

Published: April 17, 2023

SETBP1 mutation determines sensitivity to immune checkpoint inhibitors in melanoma and NSCLC.

SETBP1 mutation determines sensitivity to immune checkpoint inhibitors in melanoma and NSCLC.

Journal: Aging

Published: April 11, 2023

A mutational signature and significantly mutated driver genes associated with immune checkpoint inhibitor response across multiple cancers.

A mutational signature and significantly mutated driver genes associated with immune checkpoint inhibitor response across multiple cancers.

Journal: International immunopharmacology

Published: November 18, 2022

Fatty Acid Synthase Mutations Predict Favorable Immune Checkpoint Inhibitor Outcome and Response in Melanoma and Non-Small Cell Lung Cancer Patients.

Fatty Acid Synthase Mutations Predict Favorable Immune Checkpoint Inhibitor Outcome and Response in Melanoma and Non-Small Cell Lung Cancer Patients.

Journal: Cancers

Published: October 29, 2022

Identification and Validation of RELN Mutation as a Response Indicator for Immune Checkpoint Inhibitor Therapy in Melanoma and Non-Small Cell Lung Cancer.

Identification and Validation of RELN Mutation as a Response Indicator for Immune Checkpoint Inhibitor Therapy in Melanoma and Non-Small Cell Lung Cancer.

Journal: Cells

Published: October 14, 2022

HSPG2 Mutation Association with Immune Checkpoint Inhibitor Outcome in Melanoma and Non-Small Cell Lung Cancer.

HSPG2 Mutation Association with Immune Checkpoint Inhibitor Outcome in Melanoma and Non-Small Cell Lung Cancer.

Journal: Cancers

Published: June 06, 2022

Showing 1-12 of 27

Last Updated: 09/26/2026